|
Index of reports
> Cases with Stress Cardiomyopathy (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Amerge (Naratriptan) where reactions include stress cardiomyopathy. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Amerge side effects in
Reported by a pharmacist from Japan on 2011-12-28
Patient:
Reactions: Troponin T Increased, Overdose, Brain Natriuretic Peptide Increased, Chest Pain, Acute Coronary Syndrome, Stress Cardiomyopathy, Electrocardiogram ST Segment Elevation, Vasospasm
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Amerge
Possible Amerge side effects in
Reported by a physician from Japan on 2011-11-29
Patient:
Reactions: Brain Natriuretic Peptide Increased, Overdose, Chest Pain, Troponin T Increased, Stress Cardiomyopathy, Vasospasm
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Amerge
Possible Amerge side effects in
Reported by a physician from Japan on 2011-11-10
Patient:
Reactions: Overdose, Brain Natriuretic Peptide Increased, Chest Pain, Troponin T Increased, Stress Cardiomyopathy, Vasospasm
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Amerge
Possible Amerge side effects in
Reported by a physician from Japan on 2011-11-02
Patient:
Reactions: Overdose, Stress Cardiomyopathy
Drug(s) suspected as cause:
Amerge
|
